Clik here to view.
Project Data Sphere, LLC任命Kald Abdallah博士为Project Data Sphere总监
北卡罗来纳州卡利 (美国商业资讯)–Project Data Sphere, LLC任命医学博士和哲学博士Kald Abdallah为Project Data Sphere总监，负责www.ProjectDataSphere.org数据共享平台的持续快速发展。该平台提供广泛的癌症研究数据库访问权限，促成前所未有的研究合作，以解决复杂的科学问题。 Project Data Sphere,...
View ArticleClik here to view.
《临床肿瘤学杂志》发表口服REVLIMID联合标准R-CHOP治疗弥漫大B细胞淋巴瘤患者的临床研究结果，总缓解率达到98%，完全缓解率达到80%
新泽西州萨米特 (美国商业资讯) — Celgene Corporation (NASDAQ:CELG)今天宣布，一项评估REVLIMID®（来那度胺）联合利妥昔单抗、环磷酰胺、盐酸多柔比星、硫酸长春新碱和泼尼松(R-CHOP)用于初治弥漫大B细胞淋巴瘤 (DLBCL)的研究结果在《临床肿瘤学杂志》印刷版出版之前在线发表。 该研究为II期、开放、单组研究，研究者是梅奥诊所(Mayo...
View ArticleClik here to view.
Article 4
米ニュージャージー州サミット （ビジネスワイヤ） — セルジーン・コーポレーション（NASDAQ:CELG）は本日、未治療のびまん性大細胞型B細胞性リンパ腫（DLBCL）患者を対象とするレブラミド（レナリドミド）とリツキシマブ、シクロホスファミド、ドキソルビシン塩酸塩、ビンクリスチン硫酸塩、プレドニゾン（R-CHOP）の併用療法を評価する試験の結果が、印刷版に先駆けてJournal of...
View ArticleClik here to view.
Beigene Enrolls First Patient in Phase 1 Study of BGB-3111
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced that it has dosed the first patient in a Phase 1...
View ArticleClik here to view.
Brainlab: First Patient Treatment with Revolutionary New Radiosurgery...
MUNICH, Germany New Automatic Brain Metastases Planning* software by Brainlab has been clinically used to successfully deliver fast, efficient radiosurgery treatment to a patient with metastatic...
View ArticleClik here to view.
BeiGene Expands Management Team with Two Strategic Senior Positions
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the additions of two senior members to the...
View ArticleClik here to view.
World Economic Forum Selects Labcyte as 2015 Technology Pioneer
SUNNYVALE, Calif. Labcyte Inc., the company revolutionizing life science research with the Echo® acoustic liquid handler, was recognized by the World Economic Forum for demonstrating the ability to...
View ArticleClik here to view.
エリテックが急性骨髄性白血病における第IIb相試験で2回目の肯定的なDSMB評価結果を発表
仏リヨン 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
ボストン・ストラテジクス: 富士フイルムの抗がん剤FF-10501の再発・難治性骨髄異形成症候群（MDS）対象の第一相臨床試験を開始
ボストン （ビジネスワイヤ） — 米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発会社Boston Strategics Corporation（BSC）は、富士フイルムの子会社 FUJI FILM Pharmaceuticals U.S.A., Inc. (FPHU)...
View ArticleClik here to view.
Elekta: Enhanced collaboration with Toshiba strengthens Elekta’s position in...
TOKYO Regulatory News: In an agreement signed today in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corporation (TMSC) wider distribution rights regarding linear accelerator (linac) sales....
View ArticleClik here to view.
Teleflex to Present for the First Time at the 32nd Annual World Congress of...
WAYNE, Pa. Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present for the first time at the 32nd Annual World Congress...
View ArticleClik here to view.
BSD Medical Completes Sale of Fourth BSD-2000 Hyperthermia System to Taiwan...
SALT LAKE CITY BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced...
View ArticleClik here to view.
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) has entered an exclusive agreement with a wholly-owned subsidiary of Hainan Sinotau Pharmaceutical Co., Ltd., a pharmaceutical...
View ArticleClik here to view.
TEAC Introduces UR-4MD: It’s Never Been So Easy to Capture & Reliably Store...
TOKYO TEAC Corporation (hereinafter TEAC) (TOKYO:6803), the world leader in medical imaging, recording and filing solutions, today announced a new high-definition medical imaging recorder to be...
View ArticleClik here to view.
米国ボストン・ストラテジクス社: 次世代型医薬品R&Dプラットフォーム（“True” Open Innovation™）を駆使してグローバル医薬品開発
ボストン （ビジネスワイヤ） — Boston Strategics Corporation（BSC）は、米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発（R&D）会社です。既成インフラに依らず、独自のグローバル・ネットワークを駆使する“True” Open Innovation™...
View ArticleClik here to view.
Pathway Genomics Launches BreastTrue NGS High Risk Breast Cancer Panel with...
SAN DIEGO Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BreastTrueTM High...
View ArticleClik here to view.
Altor BioScience and Shenzhen Beike Biotechnology Announce License Agreement...
MIRAMAR, Fla. & SHENZHEN, China Altor BioScience Corporation (Altor), a U.S.-based developer of novel cancer immunotherapies, and Shenzhen Beike Biotechnology Co., Ltd. (Beike), a leading...
View ArticleClik here to view.
Medline: The Search is on for Australia and New Zealand’s Most Popular Pink...
MUNDELEIN, Ill. Thousands of people across Australia and New Zealand – from healthcare professionals, breast cancer survivors, friends and families – have been hard at work choreographing pink glove...
View ArticleClik here to view.
Pathway Genomics上市检测乳腺癌高危基因PALB2的BreastTrue NGS试剂盒
圣迭戈 (美国商业资讯) — Pathway Genomics Corporation是经过CLIA和CAP认证的临床实验室，总部在加州圣迭戈，为全球提供基因检测服务，该公司今天宣布上市BreastTrueTM High Risk Panel，这是一种通过血液或唾液进行测序的下一代检测，它凭借缺失/重复分析，检测七种乳腺癌高危易感基因（包括BRCA1、BRCA2 和 PALB2）的突变。...
View ArticleClik here to view.
Mitsubishi Electric to Deliver Pencil Beam Scanning System for Cancer Therapy...
TOKYO Mitsubishi Electric Corporation (TOKYO:6503) announced today that it will provide its innovative Pencil Beam Scanning system for cancer treatment at SAGA Heavy Ion Medical Accelerator in Tosu...
View Article